Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

US Patent 8236819 · Granted Aug 7, 2012

Estimated economic value: $54,274,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
HMOX1 inducers2024
Poly-ADP ribose polymerase (PARP) inhibitors2024
Crystalline and salt forms of PPAR agonist compounds2024
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereo2023
Crystalline and salt forms of PPAR agonist compounds2022
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereo2022
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmac2021
Antidiabetic heterocyclic compounds2021
Poly-ADP ribose polymerase (PARP) inhibitors2021
USP30 inhibitors2021
Antidiabetic spirochroman compounds2021